{"pmid":32259325,"title":"Strengthening the Power of Nurses in Combating COVID-19.","text":["Strengthening the Power of Nurses in Combating COVID-19.","In December 2019, several novel coronavirus infections were firstly reported in Wuhan, Hubei Province in China, and the outbreak is quickly expanding locally and globally. World Health Organization (World Health Organization, 2020a) announced the coronavirus epidemic as an \"International Public Health Emergency of International Concern (PHEIC)\" on January 30, 2020.","J Nurs Manag","Zhang, Yuxia","32259325"],"abstract":["In December 2019, several novel coronavirus infections were firstly reported in Wuhan, Hubei Province in China, and the outbreak is quickly expanding locally and globally. World Health Organization (World Health Organization, 2020a) announced the coronavirus epidemic as an \"International Public Health Emergency of International Concern (PHEIC)\" on January 30, 2020."],"journal":"J Nurs Manag","authors":["Zhang, Yuxia"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259325","week":"202015|Apr 06 - Apr 12","doi":"10.1111/jonm.13023","source":"PubMed","locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663450393451954176,"score":7.9164424,"similar":[{"pmid":32270568,"title":"Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital.","text":["Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019-2020: Sichuan Cancer Hospital.","Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons. This article is protected by copyright. All rights reserved.","Head Neck","Cai, Yong-Cong","Wang, Wei","Li, Chao","Zeng, Din-Fen","Zhou, Yu-Qiu","Sun, Rong-Hao","Jiang, Hua","Guo, Hui","Wang, Shao-Xin","Jiang, Jian","32270568"],"abstract":["Since December 2019, a number of patients with novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei Province, China. NCP has rapidly spread to other provinces and cities in China and other countries in the world. Due to the rapid increase in reported cases in China and around the world, on January 30, 2020, the World Health Organization (WHO) Emergency Committee announced that NCP is a Public Health Emergency of International Concern (PHEIC). However, there are relatively few suggestions and measures for tumor patients, especially patients with head and neck tumors. This article summarizes the prevention and control of disease in our medical institution to provide a reference for front-line head and neck surgeons. This article is protected by copyright. All rights reserved."],"journal":"Head Neck","authors":["Cai, Yong-Cong","Wang, Wei","Li, Chao","Zeng, Din-Fen","Zhou, Yu-Qiu","Sun, Rong-Hao","Jiang, Hua","Guo, Hui","Wang, Shao-Xin","Jiang, Jian"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270568","week":"202015|Apr 06 - Apr 12","doi":"10.1002/hed.26161","keywords":["2019 novel coronavirus diseases","head and neck tumor","infectious diseases","medical protection"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663620083105136641,"score":185.13408},{"pmid":32141588,"title":"Coronavirus Disease 2019 outbreak: preparedness and readiness of countries in the Eastern Mediterranean Region.","text":["Coronavirus Disease 2019 outbreak: preparedness and readiness of countries in the Eastern Mediterranean Region.","On 31 December 2019, a cluster of acute respiratory illness was reported from China and later confirmed as novel coronavirus on 7 January 2020. This virus is the same member of the coronavirus family that caused the severe acute respiratory syndrome (SARS-CoV) reported in China 2003, and Middle East respiratory syndrome (MERS-CoV) reported in Saudi Arabia in 2012. The initial cases have been linked to a live seafood market in Wuhan, China, and the specific animal source is yet to be determined. The detection of this new virus in humans without knowing the source of the infection has raised greatly heightened concerns not only in China, but also internationally. To date, the outbreak has spread to most provinces in China and 25 other countries within a relatively short period. Consequent to its spread, Dr Tedros Ghebreyesus, Director General of the World Health Organization (WHO), declared the outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020.","East Mediterr Health J","Al-Mandhari, Ahmed","Samhouri, Dalia","Abubakar, Abdinasir","Brennan, Richard","32141588"],"abstract":["On 31 December 2019, a cluster of acute respiratory illness was reported from China and later confirmed as novel coronavirus on 7 January 2020. This virus is the same member of the coronavirus family that caused the severe acute respiratory syndrome (SARS-CoV) reported in China 2003, and Middle East respiratory syndrome (MERS-CoV) reported in Saudi Arabia in 2012. The initial cases have been linked to a live seafood market in Wuhan, China, and the specific animal source is yet to be determined. The detection of this new virus in humans without knowing the source of the infection has raised greatly heightened concerns not only in China, but also internationally. To date, the outbreak has spread to most provinces in China and 25 other countries within a relatively short period. Consequent to its spread, Dr Tedros Ghebreyesus, Director General of the World Health Organization (WHO), declared the outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020."],"journal":"East Mediterr Health J","authors":["Al-Mandhari, Ahmed","Samhouri, Dalia","Abubakar, Abdinasir","Brennan, Richard"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141588","week":"202010|Mar 02 - Mar 08","doi":"10.26719/2020.26.2.136","source":"PubMed","locations":["Wuhan","China","Saudi Arabia"],"countries":["Saudi Arabia","China"],"countries_codes":["SAU|Saudi Arabia","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352134190497792,"score":151.31941},{"pmid":32192278,"title":"WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.","text":["WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.","To discuss whether the coronavirus disease 2019 (COVID-19) outbreak constitutes a Public Health Emergency of International Concern (PHEIC), World Health Organization (WHO) organized the 15-member International Health Regulations Emergency Committee (EC). On January 22-23 and January 30, 2020, EC convened and discussed whether the situation in China and other countries would constitute PHEIC and issued recommendations for WHO, China and the international community. Based on the recommendations of EC, WHO declared the COVID-19 outbreak a PHEIC. One of the purposes of the declaration of PHEIC was to alarm countries with weak public health infrastructures to prepare promptly for emerging infectious diseases (EID) and provide WHO with a framework for proactively supporting those countries. On February 3, 2020, WHO proposed the 2019 COVID-19 Strategic Preparedness and Response Plan, which includes accelerating research and development (R&D) processes as one of three major strategies. On February 11-12, 2020, WHO held the Global Research and Innovation Forum: Towards a Research Roadmap for COVID-19. The fact that a COVID-19 R&D forum was the first meeting convened after the PHEIC declaration testifies to the importance of R&D in response to EID. Korea has demonstrated a remarkable capacity in its laboratory response by conducting high-throughput COVID-19 testing and utilizing innovative drive-through samplings. These measures for early detection and screening of cases should be followed by full efforts to produce research-based evidence by thoroughly analyzing epidemiological, clinical and immunological data, which will facilitate the development of vaccines and therapeutics for COVID-19. It is expected that Korea plays a global partner for COVID-19 research by actively participating in immediate and mid/long-term priorities jointly led by WHO and global partners.","Epidemiol Health","Jee, Youngmee","32192278"],"abstract":["To discuss whether the coronavirus disease 2019 (COVID-19) outbreak constitutes a Public Health Emergency of International Concern (PHEIC), World Health Organization (WHO) organized the 15-member International Health Regulations Emergency Committee (EC). On January 22-23 and January 30, 2020, EC convened and discussed whether the situation in China and other countries would constitute PHEIC and issued recommendations for WHO, China and the international community. Based on the recommendations of EC, WHO declared the COVID-19 outbreak a PHEIC. One of the purposes of the declaration of PHEIC was to alarm countries with weak public health infrastructures to prepare promptly for emerging infectious diseases (EID) and provide WHO with a framework for proactively supporting those countries. On February 3, 2020, WHO proposed the 2019 COVID-19 Strategic Preparedness and Response Plan, which includes accelerating research and development (R&D) processes as one of three major strategies. On February 11-12, 2020, WHO held the Global Research and Innovation Forum: Towards a Research Roadmap for COVID-19. The fact that a COVID-19 R&D forum was the first meeting convened after the PHEIC declaration testifies to the importance of R&D in response to EID. Korea has demonstrated a remarkable capacity in its laboratory response by conducting high-throughput COVID-19 testing and utilizing innovative drive-through samplings. These measures for early detection and screening of cases should be followed by full efforts to produce research-based evidence by thoroughly analyzing epidemiological, clinical and immunological data, which will facilitate the development of vaccines and therapeutics for COVID-19. It is expected that Korea plays a global partner for COVID-19 research by actively participating in immediate and mid/long-term priorities jointly led by WHO and global partners."],"journal":"Epidemiol Health","authors":["Jee, Youngmee"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32192278","week":"202012|Mar 16 - Mar 22","doi":"10.4178/epih.e2020013","keywords":["COVID-19","Emergency Committee","International Health Regulations","Public Health Emergency of International Concern","Research and development"],"source":"PubMed","locations":["China","South Korea"],"countries":["Korea, Republic of","China"],"countries_codes":["KOR|Korea, Republic of","CHN|China"],"weight":0,"_version_":1663352133478514688,"score":142.34985},{"pmid":32277533,"title":"Emergency measures for acute oral mucosa diseases during the outbreak of COVID-19.","text":["Emergency measures for acute oral mucosa diseases during the outbreak of COVID-19.","Since the first case of novel coronavirus pneumonia was diagnosed in Wuhan, China, in December 2019, the disease has broken out all over the world, and the number of worldwide confirmed cases has exceeded 640000 up to March 30, 2020. On January 30, 2020, WHO upgraded the outbreak of the novel coronavirus disease 2019 (COVID-19) to a public health emergency of international concern (PHEIC). More than two months passed, given that there are still a few new confirmed cases in China every day, and the number of new cases in Italy, Spain, United States of America, Iran (Islamic Republic of) has increased rapidly in recently, the complete control of the outbreak on a global scale remains a difficult process.","Oral Dis","Guo, Yiqing","Yuan, Changqing","Wei, Changlei","32277533"],"abstract":["Since the first case of novel coronavirus pneumonia was diagnosed in Wuhan, China, in December 2019, the disease has broken out all over the world, and the number of worldwide confirmed cases has exceeded 640000 up to March 30, 2020. On January 30, 2020, WHO upgraded the outbreak of the novel coronavirus disease 2019 (COVID-19) to a public health emergency of international concern (PHEIC). More than two months passed, given that there are still a few new confirmed cases in China every day, and the number of new cases in Italy, Spain, United States of America, Iran (Islamic Republic of) has increased rapidly in recently, the complete control of the outbreak on a global scale remains a difficult process."],"journal":"Oral Dis","authors":["Guo, Yiqing","Yuan, Changqing","Wei, Changlei"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277533","week":"202015|Apr 06 - Apr 12","doi":"10.1111/odi.13350","keywords":["emergency measures","novel coronavirus diseases 2019 (COVID-19)","oral mucosal diseases"],"source":"PubMed","locations":["Wuhan","China","China","Italy","Spain","Iran"],"countries":["Iran, Islamic Republic of","Spain","China","Italy"],"countries_codes":["IRN|Iran, Islamic Republic of","ESP|Spain","CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663798882910339072,"score":139.02486},{"pmid":32081569,"title":"Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.","text":["Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.","The 2019-nCoV infection that is caused by a novel strain of coronavirus was first detected in China in the end of December 2019 and declared a public health emergency of international concern by the World Health Organization on January 30, 2020. Community pharmacists in one of the first areas that had confirmed cases of the viral infection, Macau, joined the collaborative force in supporting the local health emergency preparedness and response arrangements. This paper aimed to improve the understanding of community pharmacists' role in case of 2019-CoV outbreak based on the practical experiences in consultation with the recommendations made by the International Pharmaceutical Federation on the Coronavirus 2019-nCoV outbreak.","Res Social Adm Pharm","Ung, Carolina Oi Lam","32081569"],"abstract":["The 2019-nCoV infection that is caused by a novel strain of coronavirus was first detected in China in the end of December 2019 and declared a public health emergency of international concern by the World Health Organization on January 30, 2020. Community pharmacists in one of the first areas that had confirmed cases of the viral infection, Macau, joined the collaborative force in supporting the local health emergency preparedness and response arrangements. This paper aimed to improve the understanding of community pharmacists' role in case of 2019-CoV outbreak based on the practical experiences in consultation with the recommendations made by the International Pharmaceutical Federation on the Coronavirus 2019-nCoV outbreak."],"journal":"Res Social Adm Pharm","authors":["Ung, Carolina Oi Lam"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32081569","week":"20208|Feb 17 - Feb 23","doi":"10.1016/j.sapharm.2020.02.003","keywords":["*2019-nCoV","*Community pharmacy","*Macau","*Outbreak","*Pharmacist"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352134558547968,"score":134.2206}]}